Skip to content
‹ Back to IndustriesSciences

Terminator-Inspired Shape-Shifting Robot Becomes Reality. What Use Cases Does It Have in Manufacturing?

Thirty-two years after the release of Terminator 2, groundbreaking research in phase-shifting materials has made it possible for a real-life shape-shifting robot to exist. This new robot has the same ability as the T-1000 to transform into a liquid shape and pass through barriers. However, that’s where the similarities end. The new robot was…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By carey.scott · · Liquid Metal RobotMagnetoactive Phase Transitional MatterManufacturingMptm
Share

Key takeaways

01

Thirty-two years after the release of Terminator 2, groundbreaking research in phase-shifting materials has made it possible for a real-life shape-shifting robot to exist.

02

This new robot has the same ability as the T-1000 to transform into a liquid shape and pass through barriers.

03

However, that’s where the similarities end.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Thirty-two years after the release of Terminator 2, groundbreaking research in phase-shifting materials has made it possible for a real-life shape-shifting robot to exist. This new robot has the same ability as the T-1000 to transform into a liquid shape and pass through barriers. However, that’s where the similarities end.

The new robot was developed by a team from The Chinese University of Hong Kong under the direction of Dr. Chengfeng Pan. It is made up of a newly developed phase-shifting material researchers call “magnetoactive liquid-solid phase transitional matter,” or MPTM. Magnetic particles embedded in the material of the robot allow users to control it. This means it can be heated and cooled on demand using an alternating magnetic field to melt it into a liquid and then solidify it again.

This research is just one of the many advancements shaping the future of robotics and its use cases. Scientists are hoping that this discovery will one day be of use in a variety of fields, including medicine and assembly lines. MPTM could make it easier to solder and screw parts in hard-to-reach places, for example, but that’s hopefully just scratching the surface of its utility.

How can the manufacturing industry benefit from a shape-shifting robot? And are there any manufacturing applications where a flexible structure can make a huge difference? We reached out to Rhonda DiBachi, CEO of HeyScottie, for her expert opinion and analysis on this T-1000 tech. Rhonda has been implementing manufacturing techniques for companies since the 1980s and founded numerous startups for tech and manufacturing. 

Rhonda’s Thoughts:

“I don’t know of any manufacturing applications for this new material called MPTM or Magnetoactive Phase Transitional Matter. It’s early days. I do know of some applications of a similar kind of material called a shape memory alloy. That’s metals that change their shape depending upon changes in temperature and pressure.

I know that those are used in pneumatic and flow control systems to change valves. That’s interesting. An interesting application for this new kind of material, MPTM, I would think would be 3D printing, metal 3D printing. You could create struts using this material and when you’re building up the part you could use the struts, they would be structural.

But then when you’re done building up the part, you don’t need the struts anymore. And, if you could flip a switch and make them change their shape, they might be able to just slither out, making removal quite a bit easier than it is right now. Could be interesting.”

Article written by Sonia Gossai.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

C
carey.scott
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Why shared auto-injectors keep forcing rebuilt device files

Why shared auto-injectors keep forcing rebuilt device files

Vertex Knight co-founder Fubin Wu names digitalization, personalization and large-volume delivery as the trends reshaping drug delivery devices, arguing structured data can end rebuilding design files for shared auto-injectors. ISPE says no regulatory pathway exists for platform devices, and ONdrugDelivery counts 182 large-volume subcutaneous biologics, about 15% of the injectable pipeline.

  • 01A device shared across drug products still triggers repeated design control work for each new combination product, and ISPE's November 2025 article says no regulatory pathway yet exists to approve a platform device.
  • 02FDA's May 2024 draft platform technology designation under section 506K is written for drug product applications, so device design files sit outside it.
  • 03Large-volume subcutaneous biologics above 2 mL numbered 182 in a January 2025 ONdrugDelivery review, about 15% of IV and SC agents; Advanced Drug Delivery Reviews reported in July 2026 that volumes up to 25 mL are now pursued.

Oct 22, 2026

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's Pingshan prefilled syringe plant in Shenzhen won the Innovation (Novel Technology) category at ISPE's 2026 Facility of the Year Awards. In the transcript ISPE posted with its podcast, CaiXue Wei describes vertical design, AGV-assisted transfer, AI inspection and 5G-MEC as one integrated system built around a 330 million-syringe annual capacity; Hepalink's own release adds a 24-meter warehouse, sub-10 millisecond 5G and 24,000-unit-an-hour inspection.

  • 01Hepalink's 24-meter automated warehouse raised space utilization 52 percent over a traditional layout on a land-scarce Shenzhen site supporting 330 million syringes a year.
  • 02AGVs pass material through vaporized hydrogen peroxide chambers straight into Grade A isolators, and Hepalink credits the zero-touch flow for a 100 percent first media fill.

Oct 22, 2026

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers University of Technology's AI scientist Eve analyzed about 60,000 public yeast records, came up with almost 2,000 testable ideas, and took full charge of planning the experiments and telling other robots what to do, according to CORDIS. Humans handled safety checks and plate moving.

  • 01The key step for company labs is translation: turning hypotheses into machine-executable protocols and getting contextualized results back to the reasoning layer fast.

Oct 19, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

C
carey.scott

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512